Physician Office Laboratory Markets, 3rd Edition

DUBLIN, Sept. 23, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Physician Office Laboratory Markets, 3rd Edition" report to their offering.

http://photos.prnewswire.com/prnh/20130307/600769

This report, Physician Office Laboratory Markets is Kalorama's complete review of an important segment of the IVD industry. Physician office laboratories are diverse in their capabilities and setting. Individual practitioners may simply perform reimbursable, in-office pregnancy and glucose tests. Some specialty practices and clinics run CBCs and chemistry panels using small lab and benchtop automated analyzers requiring moderate complexity CLIA compliance. Medicare physician filings also indicate POLs perform moderate complexity infectious disease tests using plate immunoassays and molecular assays as well as in-situ hybridization tests using tissue samples.

While many tests run at POLs are simple in nature, more complex tests are being run

This report contains

• Market Size Estimates for IVD Tests in POL Settings
• Forecasts to 2018
• POL Data
• Important Trends
• Most Common POL Tests
• Reimbursement and Regulation
• International POL Overview and Country Analysis
• Corporate Profiles

The POL market encompasses a variety of institutions beyond physician practices, including specialty and multispecialty clinics; other primary care and urgent care clinics; and outpatient clinics not located or associated with a hospital (or hospital lab) or outpatient surgical services. In general, the POL market includes tests which are:

• physically performed in a physician office setting or lab located on the premises of the clinic or practice (not an associated hospital)
• performed at the time of a consultation with a physician or other healthcare professional (nurse practitioner, pharmacist)
• reportable to the patient are provide results to be used during the medical visit or same day as the visit
• used for screening, diagnosis or monitoring purposes not performed by anatomic pathologists or similar pathology practices that operate as physician practices or offices but provide histology, microscopy, and high complexity testing services as outreach (outside patients and samples) and with results not available during the visit or in conjunction with one visit

What competitors are succeeding in this market? What are the most profitable tests, and what growth levels can diagnostic companies expect in the future? How will regulations affect this industry? This report answers these questions. The report takes a bold look into the technologies and trends in physician office testing and laboratories (POLs) with a special focus on the economics of test use in on-site patient care. Among the type of physician conducted tests covered in this market research report:

Chemistry Panels

• Coag PT
• Lipids
• Hemato - CBC
• Glucose
• HbA1c
• Rapid Flu
• Anemia Ferritin, Iron
• Preg/LH
• Urinalysis
• PSA
• TSH
• FOB
• Cardiac Markers
• Hepatitis
• HIV
• Histology
• Microbiology culture
• Strep A
• Autoimmune
• Sed Rate
• H. pylori
• Cancer Markers
• CRP
• Hgb
• Respiratory Viruses
• STDs
• Allergy
• DAU
• Infectious diseases
• Microalbumin
• TDM
• Other

A truly global report, the 3rd edition this report discusses the POL market in the following countries:

• The United States
• Canada - Provinces Determine POL and POCT Coverage
• United Kingdom
• Germany
• Italy
• France
• Switzerland
• Japan
• Australia
• China
• India

Key Topics Covered:

ONE: EXECUTIVE SUMMARY

TWO: INTRODUCTION

THREE: MARKET AND TECHNOLOGICAL DYNAMICS IN POL TESTING

FOUR: POL TESTING IN WORLD MARKETS

FIVE: TOP TIER IVD PLAYERS

SIX: OTHER POL COMPANIES

For more information visit http://www.researchandmarkets.com/research/255m5q/physician_office

Media Contact: Laura Wood, +353-1-481-1716, press@researchandmarkets.net